• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AUNA2:一种新型的非综合征性缓慢进行性听觉突触病/听觉神经病,具有常染色体显性遗传。

AUNA2: A Novel Type of Non-Syndromic Slowly Progressive Auditory Synaptopathy/Auditory Neuropathy with Autosomal-Dominant Inheritance.

作者信息

Lang-Roth Ruth, Fischer-Krall Eva, Kornblum Cornelia, Nürnberg Gudrun, Meschede Dieter, Goebel Ingrid, Nürnberg Peter, Beutner Dirk, Kubisch Christian, Walger Martin, Volk Alexander E

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, University of Cologne, Cologne, Germany.

出版信息

Audiol Neurootol. 2017;22(1):30-40. doi: 10.1159/000474929. Epub 2017 Jun 10.

DOI:10.1159/000474929
PMID:28601886
Abstract

BACKGROUND

Auditory synaptopathy/neuropathy (AS/AN) is a heterogeneous disorder, which may be caused by environmental factors like postnatal hyperbilirubinemia or by genetic factors. The genetic forms are subdivided into syndromic and non-syndromic types, and show different inheritance patterns with a strong preponderance of autosomal-recessive forms. To date, only a single locus for non-syndromic autosomal-dominant AS/AN (AUNA1) has been reported in a single family, in which a non-coding DIAPH3 mutation was subsequently described as causative.

MATERIALS AND METHODS

Here, we report detailed clinical data on a large German AS/AN family with slowly progressive postlingual hearing loss. Affected family members developed their first symptoms in their second decade. Moderate hearing loss in the fourth decade then progressed to profound hearing impairment in older family members. Comprehensive audiological and neurological tests were performed in the affected family members. Genetic testing comprised linkage analyses with polymorphic markers and a genome-wide linkage analysis using the Affymetrix GeneChip® Human Mapping 250K.

RESULTS AND CONCLUSION

We identified a large family with autosomal-dominant AS/AN. By means of linkage analyses, the AUNA1 locus was excluded, and putatively linked regions on chromosomal bands 12q24 and 13q34 were identified as likely carrying the second locus for autosomal-dominant AS/AN (AUNA2). AUNA2 is associated with a slowly progressive postlingual hearing loss without any evidence for additional symptoms in other organ systems.

摘要

背景

听觉突触病变/神经病变(AS/AN)是一种异质性疾病,可能由出生后高胆红素血症等环境因素或遗传因素引起。遗传形式可细分为综合征型和非综合征型,呈现不同的遗传模式,其中常染色体隐性形式占主导。迄今为止,仅在一个家族中报道了非综合征型常染色体显性AS/AN(AUNA1)的一个基因座,随后在该家族中描述了一种非编码DIAPH3突变是致病原因。

材料与方法

在此,我们报告了一个大型德国家族的详细临床数据,该家族患有缓慢进展的语后听力损失。受影响的家庭成员在第二个十年出现了最初症状。在第四个十年出现中度听力损失,随后在年长的家庭成员中发展为重度听力障碍。对受影响的家庭成员进行了全面的听力学和神经学检查。基因检测包括使用多态性标记进行连锁分析以及使用Affymetrix GeneChip® Human Mapping 250K进行全基因组连锁分析。

结果与结论

我们鉴定出一个患有常染色体显性AS/AN的大家族。通过连锁分析,排除了AUNA1基因座,并确定染色体带12q24和13q34上的推定连锁区域可能携带常染色体显性AS/AN的第二个基因座(AUNA2)。AUNA2与缓慢进展的语后听力损失相关,且没有任何证据表明其他器官系统存在额外症状。

相似文献

1
AUNA2: A Novel Type of Non-Syndromic Slowly Progressive Auditory Synaptopathy/Auditory Neuropathy with Autosomal-Dominant Inheritance.AUNA2:一种新型的非综合征性缓慢进行性听觉突触病/听觉神经病,具有常染色体显性遗传。
Audiol Neurootol. 2017;22(1):30-40. doi: 10.1159/000474929. Epub 2017 Jun 10.
2
Familial auditory neuropathy.家族性听觉神经病
Laryngoscope. 2003 Sep;113(9):1623-9. doi: 10.1097/00005537-200309000-00041.
3
A mutation in ATP11A causes autosomal-dominant auditory neuropathy type 2.ATP11A基因的突变会导致常染色体显性遗传性2型听觉神经病。
Hum Mol Genet. 2023 Mar 20;32(7):1083-1089. doi: 10.1093/hmg/ddac267.
4
Progressive auditory neuropathy in patients with Leber's hereditary optic neuropathy.莱伯遗传性视神经病变患者的进行性听觉神经病
J Neurol Neurosurg Psychiatry. 2004 Apr;75(4):626-30. doi: 10.1136/jnnp.2003.017673.
5
Association of TMTC2 With Human Nonsyndromic Sensorineural Hearing Loss.TMTC2与人类非综合征性感音神经性听力损失的关联。
JAMA Otolaryngol Head Neck Surg. 2016 Sep 1;142(9):866-72. doi: 10.1001/jamaoto.2016.1444.
6
Audiologic evidence for further genetic heterogeneity at DFNA2.DFNA2基因座存在进一步遗传异质性的听力学证据。
Acta Otolaryngol. 2002 Oct;122(7):730-5.
7
[Mapping of gene underlying autosomal dominant non-syndromic hearing loss(DFNA)].[常染色体显性非综合征性听力损失(DFNA)相关基因的定位]
Yi Chuan. 2006 Dec;28(12):1489-94. doi: 10.1360/yc-006-1489.
8
Audiologic aspects of the search for DFNA20: a gene causing late-onset, progressive, sensorineural hearing loss.寻找DFNA20基因的听力学研究:一种导致迟发性、进行性感音神经性听力损失的基因
Ear Hear. 2001 Aug;22(4):279-88. doi: 10.1097/00003446-200108000-00003.
9
First confirmatory study on PTPRQ as an autosomal dominant non-syndromic hearing loss gene.首个关于 PTPRQ 作为常染色体显性非综合征性听力损失基因的确认性研究。
J Transl Med. 2019 Oct 26;17(1):351. doi: 10.1186/s12967-019-2099-5.
10
Identification of a rare COCH mutation by whole-exome sequencing : Implications for personalized therapeutic rehabilitation in an Austrian family with non-syndromic autosomal dominant late-onset hearing loss.通过全外显子组测序鉴定一种罕见的COCH突变:对奥地利一个非综合征性常染色体显性迟发性听力损失家族个性化治疗康复的意义。
Wien Klin Wochenschr. 2018 May;130(9-10):299-306. doi: 10.1007/s00508-017-1230-y. Epub 2017 Jul 21.

引用本文的文献

1
Pathogenesis and research progress of OTOF gene related auditory neuropathy: a retrospective review.OTOF基因相关听觉神经病的发病机制与研究进展:一项回顾性综述
Am J Transl Res. 2025 Mar 15;17(3):1643-1650. doi: 10.62347/JDLC8070. eCollection 2025.
2
variants associated with auditory neuropathy spectrum disorder cause apoptosis due to impaired apoptosis-inducing factor dimerization.与听觉神经病谱系障碍相关的变异导致凋亡诱导因子二聚化受损而引起细胞凋亡。
J Zhejiang Univ Sci B. 2023 Feb 15;24(2):172-184. doi: 10.1631/jzus.B2200081.
3
Familial Temperature-Sensitive Auditory Neuropathy: Distinctive Clinical Courses Caused by Variants of the Gene.
家族性温度敏感性听觉神经病:由该基因变异导致的独特临床病程
Front Cell Dev Biol. 2021 Oct 7;9:732930. doi: 10.3389/fcell.2021.732930. eCollection 2021.
4
TMTC2 variant associated with sensorineural hearing loss and auditory neuropathy spectrum disorder in a family dyad.在一个双亲家庭中,与感音神经性听力损失和听觉神经病谱系障碍相关的TMTC2变异体
Mol Genet Genomic Med. 2018 Apr 19;6(4):653-9. doi: 10.1002/mgg3.397.